The presence of MIC ligands in sera derived from patients with colorectal cancer correlated with a reduction of NKG2D expression on circulating NK cells that resulted unable to kill MIC+ autologous tumor cells [46]. This evidence concerns the gene KLRK1 and colorectal cancer.